nodes	percent_of_prediction	percent_of_DWPC	metapath
Aspartame—Lisinopril—dilated cardiomyopathy	0.508	1	CrCtD
Aspartame—SLC22A11—Furosemide—dilated cardiomyopathy	0.084	0.503	CbGbCtD
Aspartame—Spirapril—Lisinopril—dilated cardiomyopathy	0.049	0.157	CrCrCtD
Aspartame—SLC22A8—Furosemide—dilated cardiomyopathy	0.0489	0.293	CbGbCtD
Aspartame—Trandolapril—Lisinopril—dilated cardiomyopathy	0.0459	0.147	CrCrCtD
Aspartame—Ramipril—Lisinopril—dilated cardiomyopathy	0.0459	0.147	CrCrCtD
Aspartame—Enalapril—Lisinopril—dilated cardiomyopathy	0.0459	0.147	CrCrCtD
Aspartame—Lisdexamfetamine—Lisinopril—dilated cardiomyopathy	0.0459	0.147	CrCrCtD
Aspartame—Nateglinide—Lisinopril—dilated cardiomyopathy	0.041	0.131	CrCrCtD
Aspartame—Quinapril—Lisinopril—dilated cardiomyopathy	0.0389	0.124	CrCrCtD
Aspartame—SLC22A6—Furosemide—dilated cardiomyopathy	0.0341	0.204	CbGbCtD
Aspartame—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00151	0.142	CbGpPWpGaD
Aspartame—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00115	0.108	CbGpPWpGaD
Aspartame—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000962	0.0902	CbGpPWpGaD
Aspartame—TRPV1—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.000676	0.0634	CbGpPWpGaD
Aspartame—TRPV1—Ion channel transport—RYR2—dilated cardiomyopathy	0.000441	0.0413	CbGpPWpGaD
Aspartame—TRPV1—Ion channel transport—PLN—dilated cardiomyopathy	0.000429	0.0402	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—RAF1—dilated cardiomyopathy	0.000303	0.0284	CbGpPWpGaD
Aspartame—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000303	0.0284	CbGpPWpGaD
Aspartame—Spirapril—ACE—dilated cardiomyopathy	0.000297	0.158	CrCbGaD
Aspartame—Quinapril—ACE—dilated cardiomyopathy	0.000264	0.14	CrCbGaD
Aspartame—Lisinopril—ACE—dilated cardiomyopathy	0.000264	0.14	CrCbGaD
Aspartame—Ramipril—ACE—dilated cardiomyopathy	0.000256	0.136	CrCbGaD
Aspartame—Trandolapril—ACE—dilated cardiomyopathy	0.000256	0.136	CrCbGaD
Aspartame—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000231	0.0216	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000213	0.02	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000213	0.02	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000198	0.0186	CbGpPWpGaD
Aspartame—Enalapril—ACE—dilated cardiomyopathy	0.000194	0.103	CrCbGaD
Aspartame—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000193	0.0181	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000192	0.018	CbGpPWpGaD
Aspartame—Amphetamine—SLC22A5—dilated cardiomyopathy	0.000182	0.0967	CrCbGaD
Aspartame—Methamphetamine—SLC22A5—dilated cardiomyopathy	0.000169	0.0896	CrCbGaD
Aspartame—TAS1R2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000164	0.0154	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000156	0.0146	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000153	0.0144	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000149	0.014	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000149	0.014	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000139	0.013	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000138	0.0129	CbGpPWpGaD
Aspartame—TRPV1—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.000133	0.0125	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000115	0.0108	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000109	0.0103	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000109	0.0103	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000105	0.00983	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000102	0.00954	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.85e-05	0.00924	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	8.75e-05	0.00821	CbGpPWpGaD
Aspartame—TRPV1—Ion channel transport—RAF1—dilated cardiomyopathy	8.7e-05	0.00815	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.41e-05	0.00789	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.98e-05	0.00748	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.28e-05	0.00683	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.18e-05	0.00674	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.99e-05	0.00655	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.99e-05	0.00655	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.5e-05	0.00609	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.46e-05	0.00606	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.46e-05	0.00606	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.2e-05	0.00581	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.01e-05	0.00563	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AGT—dilated cardiomyopathy	5.92e-05	0.00555	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.82e-05	0.00546	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.48e-05	0.00514	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.33e-05	0.005	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.33e-05	0.005	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.97e-05	0.00466	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.95e-05	0.00465	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.71e-05	0.00442	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.57e-05	0.00429	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.45e-05	0.00417	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.45e-05	0.00417	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.13e-05	0.00388	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.11e-05	0.00385	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.05e-05	0.0038	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RAC1—dilated cardiomyopathy	3.66e-05	0.00343	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGT—dilated cardiomyopathy	3.5e-05	0.00328	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.03e-05	0.00284	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.82e-05	0.00264	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.43e-05	0.00228	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.66e-05	0.00156	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.42e-05	0.00133	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.08e-05	0.00101	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.02e-06	0.000846	CbGpPWpGaD
